ACM
OLMA icon

Altium Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Altium Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-605,000
Closed -$6.85M – 78
2024
Q1 		$6.85M Buy
605,000
+191,393
+46% +$2.47M 2.71% 14
2023
Q4 		$5.8M Buy
413,607
+78,607
+23% +$1.06M 3.94% 10
2023
Q3 		$4.14M Buy
335,000
+25,000
+8% +$255K 2.16% 18
2023
Q2 		$2.8M Buy
+310,000
New +$1.87M 2.12% 20

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Altium Capital Management's OLMA Position: Q2 2024 in Review

Altium Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2024, closing a stake of 605,000 shares — an estimated $6.85M sold.

Altium Capital Management first reported a position in OLMA in Q2 2023 and held it in 4 quarters. The position peaked at $6.85M in Q1 2024. 128 funds tracked by Wall St. Rank hold OLMA as of Q2 2024.

  • Altium Capital Management reported no remaining Olema Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Altium Capital Management sold 605,000 Olema Pharmaceuticals shares in Q2 2024, an estimated $6.85M.
  • Altium Capital Management first reported a position in Olema Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Altium Capital Management's Olema Pharmaceuticals position peaked at $6.85M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.